首页 > 最新文献

Canadian Journal of Anesthesia最新文献

英文 中文
Beliefs of physician directors on the management of devastating brain injuries at the Canadian emergency department and intensive care unit interface: a national site-level survey 加拿大急诊科与重症监护室交接处主任医师对破坏性脑损伤管理的看法:全国现场调查
Pub Date : 2024-04-03 DOI: 10.1007/s12630-024-02749-7
Piotr Wtorek, Matthew J. Weiss, Jeffrey M. Singh, Carmen Hrymak, Alecs Chochinov, Brian Grunau, Bojan Paunovic, Sam D. Shemie, Jehan Lalani, Bailey Piggott, James Stempien, Patrick Archambault, Parisa Seleseh, Rob Fowler, Murdoch Leeies

Purpose

Insufficient evidence-based recommendations to guide care for patients with devastating brain injuries (DBIs) leave patients vulnerable to inconsistent practice at the emergency department (ED) and intensive care unit (ICU) interface. We sought to characterize the beliefs of Canadian emergency medicine (EM) and critical care medicine (CCM) physician site directors regarding current management practices for patients with DBI.

Methods

We conducted a cross-sectional survey of EM and CCM physician directors of adult EDs and ICUs across Canada (December 2022 to March 2023). Our primary outcome was the proportion of respondents who manage (or consult on) patients with DBI in the ED. We conducted subgroup analyses to compare beliefs of EM and CCM physicians.

Results

Of 303 eligible respondents, we received 98 (32%) completed surveys (EM physician directors, 46; CCM physician directors, 52). Most physician directors reported participating in the decision to withdraw life-sustaining measures (WLSM) for patients with DBI in the ED (80%, n = 78), but 63% of these (n = 62) said this was infrequent. Physician directors reported that existing neuroprognostication methods are rarely sufficient to support WLSM in the ED (49%, n = 48) and believed that an ICU stay is required to improve confidence (99%, n = 97). Most (96%, n = 94) felt that providing caregiver visitation time prior to WLSM was a valid reason for ICU admission.

Conclusion

In our survey of Canadian EM and CCM physician directors, 80% participated in WLSM in the ED for patients with DBI. Despite this, most supported ICU admission to optimize neuroprognostication and patient-centred end-of-life care, including organ donation.

目的用于指导治疗破坏性脑损伤(DBI)患者的循证建议不足,导致患者在急诊科(ED)和重症监护室(ICU)交界处容易受到不一致做法的影响。我们试图了解加拿大急诊科(EM)和重症监护科(CCM)的主任医师对当前DBI患者管理实践的看法。方法我们对加拿大各地成人急诊科和重症监护室的EM和CCM主任医师进行了横断面调查(2022年12月至2023年3月)。我们的主要结果是在急诊室管理(或咨询)DBI 患者的受访者比例。我们进行了分组分析,以比较急诊科医生和重症监护室医生的信念。结果 在 303 位符合条件的受访者中,我们收到了 98 份(32%)完成的调查问卷(急诊科主任医师 46 份;重症监护室主任医师 52 份)。大多数主任医师表示参与了对急诊室中的 DBI 患者撤除维持生命措施 (WLSM) 的决定(80%,n = 78),但其中 63% 的主任医师(n = 62)表示并不经常参与。内科主任称,现有的神经诊断方法很少足以支持急诊室的 WLSM(49%,n = 48),并认为需要入住重症监护室才能提高可信度(99%,n = 97)。大多数人(96%,n = 94)认为,在 WLSM 之前提供护理人员探视时间是入住 ICU 的合理理由。结论在我们对加拿大急诊科和中医科主任医师进行的调查中,80% 的急诊科主任医师参与了针对 DBI 患者的 WLSM。尽管如此,大多数人还是支持入住重症监护室,以优化神经诊断和以患者为中心的临终关怀,包括器官捐献。
{"title":"Beliefs of physician directors on the management of devastating brain injuries at the Canadian emergency department and intensive care unit interface: a national site-level survey","authors":"Piotr Wtorek, Matthew J. Weiss, Jeffrey M. Singh, Carmen Hrymak, Alecs Chochinov, Brian Grunau, Bojan Paunovic, Sam D. Shemie, Jehan Lalani, Bailey Piggott, James Stempien, Patrick Archambault, Parisa Seleseh, Rob Fowler, Murdoch Leeies","doi":"10.1007/s12630-024-02749-7","DOIUrl":"https://doi.org/10.1007/s12630-024-02749-7","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Insufficient evidence-based recommendations to guide care for patients with devastating brain injuries (DBIs) leave patients vulnerable to inconsistent practice at the emergency department (ED) and intensive care unit (ICU) interface. We sought to characterize the beliefs of Canadian emergency medicine (EM) and critical care medicine (CCM) physician site directors regarding current management practices for patients with DBI.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>We conducted a cross-sectional survey of EM and CCM physician directors of adult EDs and ICUs across Canada (December 2022 to March 2023). Our primary outcome was the proportion of respondents who manage (or consult on) patients with DBI in the ED. We conducted subgroup analyses to compare beliefs of EM and CCM physicians.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Of 303 eligible respondents, we received 98 (32%) completed surveys (EM physician directors, 46; CCM physician directors, 52). Most physician directors reported participating in the decision to withdraw life-sustaining measures (WLSM) for patients with DBI in the ED (80%, <i>n</i> = 78), but 63% of these (<i>n</i> = 62) said this was infrequent. Physician directors reported that existing neuroprognostication methods are rarely sufficient to support WLSM in the ED (49%, <i>n</i> = 48) and believed that an ICU stay is required to improve confidence (99%, <i>n</i> = 97). Most (96%, <i>n</i> = 94) felt that providing caregiver visitation time prior to WLSM was a valid reason for ICU admission.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>In our survey of Canadian EM and CCM physician directors, 80% participated in WLSM in the ED for patients with DBI. Despite this, most supported ICU admission to optimize neuroprognostication and patient-centred end-of-life care, including organ donation.</p>","PeriodicalId":9472,"journal":{"name":"Canadian Journal of Anesthesia","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140597495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative thrombotic events following major surgery in patients with a history of COVID-19: a retrospective cohort analysis of commercially insured beneficiaries in the USA 有 COVID-19 病史的大手术患者术后血栓事件:对美国商业保险受益人的回顾性队列分析
Pub Date : 2023-12-15 DOI: 10.1007/s12630-023-02639-4

Abstract

Purpose

We sought to evaluate the synergistic risk of postoperative thrombosis in patients with a history of COVID-19 who undergo major surgery. Major surgery and SARS-CoV-2 infection are independently associated with an increased risk of thrombosis, but the magnitude of additional risk beyond surgery conferred by a COVID-19 history on the development of perioperative thrombotic events has not been clearly elucidated in the literature.

Methods

We conducted a retrospective cohort study among commercially insured adults in the USA from March 2020 to June 2021 using the Optum Labs Data Warehouse (OLDW), a longitudinal, real-world data asset containing deidentified administrative claims and electronic health records. We compared patients with prior COVID-19 who underwent surgery with control individuals who underwent surgery without a COVID-19 history and with control individuals who did not undergo surgery with and without a COVID-19 history. We assessed the interaction of surgery and previous COVID-19 on perioperative thrombotic events (venous thromboembolism and major adverse cardiovascular events) within 90 days using multivariable logistic regression and interaction analysis.

Results

Two million and two-hundred thousand eligible patients were identified from the OLDW. Patients in the surgical cohorts were older and more medically complex than nonsurgical population controls. After adjusting for confounders, only surgical exposure—not COVID-19 history—remained associated with perioperative thrombotic events (adjusted odds ratio [aOR], 4.07; 95% confidence interval [CI], 3.81 to 4.36). The multiplicative interaction term (aOR, 1.25; 95% CI, 0.96 to 1.61) and the synergy index (0.76; 95% CI, 0.56 to 1.04) suggest minimal effect modification of prior COVID-19 on surgery with regards to overall thrombotic risk.

Conclusions

We found no evidence of synergistic thrombotic risk from previous COVID-19 in patients who underwent selected major surgery relative to the baseline thrombotic risk from surgery alone.

摘要 目的 我们试图评估有COVID-19病史并接受大手术的患者术后血栓形成的协同风险。大手术和 SARS-CoV-2 感染与血栓形成风险的增加有独立关联,但 COVID-19 病史对围手术期血栓形成事件的发生所带来的手术以外的额外风险的大小尚未在文献中明确阐明。 方法 我们利用 Optum Labs Data Warehouse(OLDW)对 2020 年 3 月至 2021 年 6 月期间在美国投保的成年人进行了一项回顾性队列研究,OLDW 是一个纵向的真实世界数据资产,包含去标识化的行政索赔和电子健康记录。我们比较了曾接受过 COVID-19 手术的患者与接受过手术但无 COVID-19 病史的对照组患者,以及未接受过手术但有或无 COVID-19 病史的对照组患者。我们使用多变量逻辑回归和交互分析评估了手术和既往 COVID-19 对 90 天内围手术期血栓事件(静脉血栓栓塞和主要不良心血管事件)的交互影响。 结果 从 OLDW 中确定了 200,000,000 名符合条件的患者。与非手术人群对照组相比,手术人群中的患者年龄更大、病情更复杂。在对混杂因素进行调整后,只有手术暴露--而非 COVID-19 病史--与围手术期血栓事件仍然相关(调整后的几率比 [aOR],4.07;95% 置信区间 [CI],3.81 至 4.36)。乘法交互项(aOR,1.25;95% CI,0.96 至 1.61)和协同作用指数(0.76;95% CI,0.56 至 1.04)表明,在总体血栓风险方面,COVID-19 对手术的影响很小。 结论 我们没有发现证据表明,相对于单独手术的血栓风险基线,既往 COVID-19 对接受选定大手术的患者具有协同血栓风险。
{"title":"Postoperative thrombotic events following major surgery in patients with a history of COVID-19: a retrospective cohort analysis of commercially insured beneficiaries in the USA","authors":"","doi":"10.1007/s12630-023-02639-4","DOIUrl":"https://doi.org/10.1007/s12630-023-02639-4","url":null,"abstract":"<h3>Abstract</h3> <span> <h3>Purpose</h3> <p>We sought to evaluate the synergistic risk of postoperative thrombosis in patients with a history of COVID-19 who undergo major surgery. Major surgery and SARS-CoV-2 infection are independently associated with an increased risk of thrombosis, but the magnitude of additional risk beyond surgery conferred by a COVID-19 history on the development of perioperative thrombotic events has not been clearly elucidated in the literature.</p> </span> <span> <h3>Methods</h3> <p>We conducted a retrospective cohort study among commercially insured adults in the USA from March 2020 to June 2021 using the Optum Labs Data Warehouse (OLDW), a longitudinal, real-world data asset containing deidentified administrative claims and electronic health records. We compared patients with prior COVID-19 who underwent surgery with control individuals who underwent surgery without a COVID-19 history and with control individuals who did not undergo surgery with and without a COVID-19 history. We assessed the interaction of surgery and previous COVID-19 on perioperative thrombotic events (venous thromboembolism and major adverse cardiovascular events) within 90 days using multivariable logistic regression and interaction analysis.</p> </span> <span> <h3>Results</h3> <p>Two million and two-hundred thousand eligible patients were identified from the OLDW. Patients in the surgical cohorts were older and more medically complex than nonsurgical population controls. After adjusting for confounders, only surgical exposure—not COVID-19 history—remained associated with perioperative thrombotic events (adjusted odds ratio [aOR], 4.07; 95% confidence interval [CI], 3.81 to 4.36). The multiplicative interaction term (aOR, 1.25; 95% CI, 0.96 to 1.61) and the synergy index (0.76; 95% CI, 0.56 to 1.04) suggest minimal effect modification of prior COVID-19 on surgery with regards to overall thrombotic risk.</p> </span> <span> <h3>Conclusions</h3> <p>We found no evidence of synergistic thrombotic risk from previous COVID-19 in patients who underwent selected major surgery relative to the baseline thrombotic risk from surgery alone.</p> </span>","PeriodicalId":9472,"journal":{"name":"Canadian Journal of Anesthesia","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138684091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hip fracture analgesia: how far ahead are we? 髋部骨折镇痛:我们还有多远?
Pub Date : 2023-12-14 DOI: 10.1007/s12630-023-02664-3
Reva Ramlogan, Vishal Uppal
{"title":"Hip fracture analgesia: how far ahead are we?","authors":"Reva Ramlogan, Vishal Uppal","doi":"10.1007/s12630-023-02664-3","DOIUrl":"https://doi.org/10.1007/s12630-023-02664-3","url":null,"abstract":"","PeriodicalId":9472,"journal":{"name":"Canadian Journal of Anesthesia","volume":"86 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138684020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving the quality and quantity of narrative feedback to anesthesiology residents: a program evaluation study 提高麻醉科住院医师叙述性反馈的质量和数量:项目评估研究
Pub Date : 2023-12-12 DOI: 10.1007/s12630-023-02680-3
Eugene Choo, Henry Bi, Mary Ellen Walker, Jennifer O’Brien
{"title":"Improving the quality and quantity of narrative feedback to anesthesiology residents: a program evaluation study","authors":"Eugene Choo, Henry Bi, Mary Ellen Walker, Jennifer O’Brien","doi":"10.1007/s12630-023-02680-3","DOIUrl":"https://doi.org/10.1007/s12630-023-02680-3","url":null,"abstract":"","PeriodicalId":9472,"journal":{"name":"Canadian Journal of Anesthesia","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138629779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using implementation science to promote the use of the fascia iliaca blocks in hip fracture care 利用实施科学在髋部骨折护理中推广使用髂筋膜块
Pub Date : 2023-12-12 DOI: 10.1007/s12630-023-02665-2
Marjorie Hammond, Vivian Law, Keelia Quinn de Launay, Jeanette Cooper, Elikem Togo, Kyle Silveira, David MacKinnon, Nick Lo, Sarah E. Ward, Stephen K. W. Chan, Sharon E. Straus, Christine Fahim, Camilla L. Wong

Purpose

There is variable and suboptimal use of fascia iliaca compartment nerve blocks (FICBs) in hip fracture care. Our objective was to use an evidence-based and theory-informed implementation science approach to analyze barriers and facilitators to timely administration of FICB and select evidence-based interventions to enhance uptake.

Methods

We conducted a qualitative study at a single centre using semistructured interviews and site observations. We interviewed 35 stakeholders including health care providers, managers, patients, and caregivers. We mapped barriers and facilitators to the Theoretical Domains Framework (TDF) and Consolidated Framework for Implementation Research (CFIR). We compared the rate and timeliness of FICB administration before and after evidence-based implementation strategies were applied.

Results

The study identified 18 barriers and 11 facilitators within seven themes of influences of FICB use: interpersonal relationships between health care professionals; clinician knowledge and skills related to FICB; roles, responsibilities, and processes for delivering FICB; perceptions on using FICB for pain; patient and caregiver perceptions on using FICB for pain; communication of hip fracture care between departments; and resources for delivering FICBs. We mapped the behaviour change domains to eight implementation strategies: restructure the environment, create and distribute educational materials, prepare patients to be active participants, perform audits and give feedback, use local opinion leaders, use champions, train staff on FICB procedures, and mandate change. We observed an increase in the rates of FICBs administered (48% vs 65%) and a decrease in the median time to administration (1.63 vs 0.81 days).

Conclusion

Our study explains why FICBs are underused and shows that the TDF and CFIR provide a framework to identify barriers and facilitators to FICB implementation. The mapped implementation strategies can guide institutions to improve use of FICB in hip fracture care.

目的髂筋膜间室神经阻滞(FICBs)在髋部骨折治疗中的应用存在变数和次优性。我们的目标是使用基于证据和理论的实施科学方法来分析FICB及时管理的障碍和促进因素,并选择基于证据的干预措施来提高吸收。方法采用半结构化访谈和现场观察,在单一中心进行定性研究。我们采访了35个利益相关者,包括卫生保健提供者、管理人员、患者和护理人员。我们将障碍和促进因素映射到理论领域框架(TDF)和实施研究综合框架(CFIR)。我们比较了采用循证实施策略前后FICB管理的比率和及时性。结果在影响FICB使用的七个主题中确定了18个障碍和11个促进因素:卫生保健专业人员之间的人际关系;与FICB相关的临床知识和技能;提供FICB的角色、职责和流程;对使用FICB治疗疼痛的看法;患者和护理人员对使用FICB治疗疼痛的看法;髋部骨折护理的科室沟通;以及提供国际商业银行的资源。我们将行为改变领域映射到八个实施策略:重组环境,创建和分发教育材料,使患者成为积极的参与者,执行审计并提供反馈,使用当地意见领袖,使用倡导者,培训员工了解FICB程序,以及改变授权。我们观察到ficb的使用率增加(48% vs 65%),中位给药时间减少(1.63 vs 0.81天)。我们的研究解释了FICB未被充分利用的原因,并表明TDF和CFIR提供了一个框架来识别FICB实施的障碍和促进因素。绘制的实施策略可以指导机构提高FICB在髋部骨折护理中的应用。
{"title":"Using implementation science to promote the use of the fascia iliaca blocks in hip fracture care","authors":"Marjorie Hammond, Vivian Law, Keelia Quinn de Launay, Jeanette Cooper, Elikem Togo, Kyle Silveira, David MacKinnon, Nick Lo, Sarah E. Ward, Stephen K. W. Chan, Sharon E. Straus, Christine Fahim, Camilla L. Wong","doi":"10.1007/s12630-023-02665-2","DOIUrl":"https://doi.org/10.1007/s12630-023-02665-2","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>There is variable and suboptimal use of fascia iliaca compartment nerve blocks (FICBs) in hip fracture care. Our objective was to use an evidence-based and theory-informed implementation science approach to analyze barriers and facilitators to timely administration of FICB and select evidence-based interventions to enhance uptake.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>We conducted a qualitative study at a single centre using semistructured interviews and site observations. We interviewed 35 stakeholders including health care providers, managers, patients, and caregivers. We mapped barriers and facilitators to the Theoretical Domains Framework (TDF) and Consolidated Framework for Implementation Research (CFIR). We compared the rate and timeliness of FICB administration before and after evidence-based implementation strategies were applied.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The study identified 18 barriers and 11 facilitators within seven themes of influences of FICB use: interpersonal relationships between health care professionals; clinician knowledge and skills related to FICB; roles, responsibilities, and processes for delivering FICB; perceptions on using FICB for pain; patient and caregiver perceptions on using FICB for pain; communication of hip fracture care between departments; and resources for delivering FICBs. We mapped the behaviour change domains to eight implementation strategies: restructure the environment, create and distribute educational materials, prepare patients to be active participants, perform audits and give feedback, use local opinion leaders, use champions, train staff on FICB procedures, and mandate change. We observed an increase in the rates of FICBs administered (48% <i>vs</i> 65%) and a decrease in the median time to administration (1.63 <i>vs</i> 0.81 days).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Our study explains why FICBs are underused and shows that the TDF and CFIR provide a framework to identify barriers and facilitators to FICB implementation. The mapped implementation strategies can guide institutions to improve use of FICB in hip fracture care.</p>","PeriodicalId":9472,"journal":{"name":"Canadian Journal of Anesthesia","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138629591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breech presentation: RCT of IV remifentalanil for ECV attempt 臀位介绍:静脉注射瑞芬他尼治疗ECV的随机对照试验
Pub Date : 2005-06-01 DOI: 10.1007/BF03023229
A. Macarthur, S. Gagnon, J. Kingdom, L. Tureanu, J. Dasan, K. Downey
{"title":"Breech presentation: RCT of IV remifentalanil for ECV attempt","authors":"A. Macarthur, S. Gagnon, J. Kingdom, L. Tureanu, J. Dasan, K. Downey","doi":"10.1007/BF03023229","DOIUrl":"https://doi.org/10.1007/BF03023229","url":null,"abstract":"","PeriodicalId":9472,"journal":{"name":"Canadian Journal of Anesthesia","volume":"40 1","pages":"A191"},"PeriodicalIF":0.0,"publicationDate":"2005-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84986674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Canadian Journal of Anesthesia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1